Blindness and Visual Impairment among Egyptian Glaucoma Patients

Eldaly, Mohamed A.; Salama, Mohsen; Eleinen, Khaled G Abu; Ghalwash, Dalia A.; Youssef, Mohamed M.; El-Shiaty, Ayman F.

doi:10.1155/2014/437548

Cited by 4 publications

(6 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…13 Glaucoma is a chronic eye disease that needs efficient and regular follow-up to avoid its potentially blinding effect. [5][6][7] Poor compliance and adherence to medications are well-known drawbacks for glaucoma patients, especially in Africa. 14 Mahmoud H 15 did an internet-based questionnaire including Egyptian ophthalmologists to assess the effect of COVID-19 on ophthalmology practice in Egypt.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Influence of COVID‑19 on the Prognosis and Medication Compliance of Glaucoma Patients in the Nile Delta Region

Awwad¹,

Masoud²

2021

OPTH

View full text Add to dashboard Cite

Objective: To assess the influence of the COVID-19 pandemic on the medication adherence and follow-up of glaucoma patients in the Nile Delta region. Setting: A tertiary care center in the Nile Delta region, Egypt. Study Design: An observational, cross-sectional study. Participants: Patients' records (2019-2020; group A) and (2020-2021; group B) were assessed for missed follow-up visits, medication adherence, number of trabeculectomies performed, and uncontrolled patients. In addition, a telephone-based questionnaire involving randomly chosen 200 patients from B.G.U. was carried out to clarify the potential causes of poor patients' compliance. Results: There was a marked decline in the number of newly diagnosed patients and patients on regular follow-up with incidence rates 0.208 and 0.088 in group (A) and group (B), respectively (P-value < 0.0001). The number of compliant patients in group B decreased with an incidence rate difference of 0.312. The number of trabeculectomies declined in group (B) with an incidence rate in group (A) 0.131 compared to 0.081 in group (B). On the other hand, the number of uncontrolled glaucoma patients increased in group B with an incidence rate difference −0.231 between the two groups. 21.5% of patients who participated in the questionnaire identified financial issues as the leading cause of non-compliance. Comorbidities (19.5%), lockdown and transportation difficulties were also highlighted. Conclusion: COVID-19 had greatly hampered glaucoma care in the Nile Delta region. As a result, we need to implement new technologies like telemedicine and improve patients' awareness of glaucoma care. Training orthoptists and using mobile glaucoma care services would also be helpful ways of managing glaucoma during that pandemic.

show abstract

Section: Discussionmentioning

confidence: 99%

“…4 Glaucoma is a chronic ocular disease that affects nearly 2% of Egyptians in the urban population and 9% in rural areas. 5 Regular and careful follow-up is crucial for this potentially blinding disease. 6 Glaucoma patients' followup visits were significantly affected by the new regulations adopted by hospitals in the fight of COVID-19.…”

Section: Introductionmentioning

confidence: 99%

Influence of COVID‑19 on the Prognosis and Medication Compliance of Glaucoma Patients in the Nile Delta Region

Awwad¹,

Masoud²

2021

OPTH

View full text Add to dashboard Cite

show abstract

“…Few regional studies have defined glaucoma as the leading cause of blindness at a prevalence rate of 2–9% in Egypt, 1.73% in Qatar, and 4.75% in Oman [ 13 – 15 ]. Glaucoma had also been found to contribute to legal blindness at a rate of 8% in a study done at Cairo University in 2014, 12.1% at Mansoura University in 2002, 19.7% at Alexandria University in 1987, and 7.6% at Al-Azhar University (Cairo) in 1989 [ 16 ].…”

Section: Discussionmentioning

confidence: 99%

Analysis of Factors Affecting Patients’ Compliance to Topical Antiglaucoma Medications in Egypt as a Developing Country Model

Hussein

Eissa

Abdelkader

2015

Journal of Ophthalmology

View full text Add to dashboard Cite

Purpose. To study factors affecting patients' compliance to antiglaucoma medications in Egypt where there are unique factors as a developing country. Patients and Methods. A cross-sectional descriptive study on 440 Egyptian patients with open angle glaucoma (OAG) recruited for over two years. The patients were thoroughly interviewed about their age, education level, duration of glaucoma, difficulty in instilling the drops, medication regimens, a family history of glaucoma, knowledge of the disease, and the presence of medical insurance. Results. 236 (53.6%) were noncompliant compared to 204 (46.4%) who were compliant. Females had a tendency for higher compliance (p=0.061). Patient age above 50 years and low level of education and negative family history of glaucoma were factors significantly associated with poor compliance (p < 0.0001). Polytherapy and lack of medical insurance could be contributing factors. Conclusion. Egyptian patients have a high rate of noncompliance compared to the average in literature. Great effort is needed in educating patients about the importance of medications and the risk and the prognosis of this disease. Economic factors must also be taken into consideration in developing countries with large number of poor patients. We recommend simplifying drug regimens, incorporating electronic dose monitors, and creating reminders for follow-up visits of glaucoma patients.

show abstract

“…In Latin America, the prevalence of patients with glaucoma was projected 3.35% and followed by China and Southeast Asia which had a prevalence ranged between 2.38% and 2.66%. (8)(9)(10) Furthermore, women were excessively affected by glaucoma and representative 59.1% of all people with glaucoma in 2020, where the women encompassed 55.4% of OAG and 69.5% of ACG affected as a result of both higher prevalence and greater longevity. Additionally, more than 51.5% of the world population over age 40 were females with glaucoma compared with males.…”

Section: Introductionmentioning

confidence: 99%

“…In the USA, several research studies revealed that by age 69, approximately 6% of black Americans have glaucoma; and their risk rises to almost 12 % after age 80. (10)(11)(12)(13) According to the National Eye Institute, (2015); Mantravadi & Vadhar, (2015); Vin, Schneider, Muir, & Rosdahl, (2015) reported that glaucoma has been called the "silent thief of sight", because the loss of vision usually occurs slowly over a long period of time. (13)(14)(15) Due to the visual disability could be avoidable among patients with glaucoma and also, the progress of ocular damage can prevent blindness through the effectiveness of the treatment among patients with glaucoma, so it is crucial to focus on the medication adherence behavior (MAB) that describes the degree to which the patient's compliance or take medications according to the prescription provided by the health-care professional.…”

Section: Introductionmentioning

confidence: 99%

Impact of Self-Efficacy Theory on Improving Adherence of Older Adults Patients With Glaucoma’s Medication

Abou-El-Soud¹,

Mohamed²

2020

JHMN

View full text Add to dashboard Cite

Purpose: This study was aimed to measure the impact of self-efficacy theory to improve medication adherence among older adults’ patients with glaucoma. Methodology: A quasi-experimental design was used to investigate the study hypotheses. Study Sample: A total of 284 older adults with glaucoma were screened to select non-adherent patients with medication. The recruited study sample was (152) who are non-adherent with glaucoma medication divided equally into (76 study group) and (76 control group). Setting: the study was conducted at the outpatient clinics of Ophthalmology at University Hospital, Shebin El-Kom, Egypt. Tools: three tools were used for the purpose of data collection (I) Bio-socio-demographic characteristics questionnaire; (II) Medication Adherence Rating Scale (III) Glaucoma Medication Self-Efficacy Scale. Findings: The findings revealed that the mean age of the studied sample was 74.86+4.63 (non-adherent to medication). Patients age and presence of more than three multiple chronic illnesses with poly-medications are the highest risk factors of adherence to medications (OR = 10.9; 95% CI 6.8 -16.32, P = 0.000); (OR = 12.6; 95% CI 8.2 -18.4, P = 0.000) and (OR = 13.2; 95% CI 7.4 -19.8, P = 0.000) respectively. Participants who received the intervention program showed a significant improvement in their self-efficacy in overcoming medication adherence barriers compared to the control group. An improvement of the self-efficacy in their ability in carrying out glaucoma medication correctly compared to the control group was shown by highly statistically significant differences between total mean scores at (t =3.426, P =.001; t =17.174, P=.000; t =18.141, P=.000) respectively. The intervention program of glaucoma medication management had a positive impact on the patients’ outcomes compared to the control group. There is a statistically significant difference between patients’ feelings and thoughts pre and post-intervention was detected. Unique contribution to theory, practice and policy: The findings confirm the effectiveness of an intervention/educational program based on self-efficacy theory in terms of improving glaucoma medication adherence among older adults. Glaucoma’s medication principles should be discussed at regular intervals based on patients' needs and the barriers they are facing.

show abstract

Blindness and Visual Impairment among Egyptian Glaucoma Patients

Cited by 4 publications

References 8 publications

Influence of COVID‑19 on the Prognosis and Medication Compliance of Glaucoma Patients in the Nile Delta Region

Influence of COVID‑19 on the Prognosis and Medication Compliance of Glaucoma Patients in the Nile Delta Region

Analysis of Factors Affecting Patients’ Compliance to Topical Antiglaucoma Medications in Egypt as a Developing Country Model

Impact of Self-Efficacy Theory on Improving Adherence of Older Adults Patients With Glaucoma’s Medication

Contact Info

Product

Resources

About